Unusual 11 Mid-Day Movers 1/13: (PHMD) (ELX) (NLST) Higher; (ECOM) (OCN) (ASPS) Lower Jan 13, 2015 12:57PM
Pre-Open Stock Movers 01/13: (PCYC) (ELX) (AAPL) Higher; (ECOM) (BGFV) (WWW) Lower (more...) Jan 13, 2015 09:21AM
Streetinsider.com Pre-Open Movers 04/08: (LUFK) (BCRX) (PCYC) Higher; (DCTH) (OMPI) (BYI) Lower Apr 8, 2013 09:07AM
Notable Analyst Rating Changes 11/01: (CRUS) (JOY) (RVBD) Upgraded; (NFLX) (ZUMZ) (RDC) Downgraded Nov 1, 2012 11:19AM
Notable Analyst Rating Changes 08/20: (ROST) (PB) (STO) Upgraded; (STEM) (STX) (PCYC) Downgraded Aug 20, 2012 10:57AM


Aug 2, 2012 08:39AM Needham & Company Downgrades Pharmacyclics (PCYC) to Hold; Taking Some Off The Table
Jun 5, 2012 07:59AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); Ibrutinib Continues to Demonstrate Impressive Efficacy/Safety
Jan 6, 2012 10:37AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); 2012 Preview - PCI-32765 Transitioning to Phase 3
Dec 23, 2011 07:35AM Needham & Company 2012 Biotech Preview
Dec 15, 2011 08:49AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); ASH Meeting Review; PCI-32765 Continues to Impress; Phase 3 Trials on Track for 2012
Nov 11, 2011 09:09AM Needham & Company Assumes Coverage on Pharmacyclics (PCYC) at Buy; Review and ASH Meeting Preview
Jun 8, 2011 08:06AM Needham & Company Maintains a 'Buy' on Pharmacyclics (PCYC); ASCO Mtg Presentation Shows Continued Robust Btk PCI-32765 Activity in CLL/SLL
May 19, 2011 08:24AM Needham & Co Highlights Seattle Genetics (SGEN), Pharmacyclics (PCYC), and Dendreon (DNDN) Ahead of ASCO
Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference
Feb 7, 2011 08:03AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); Believe Shares Move Higher in Near-Term
Jan 5, 2011 08:16AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); Updated Data for Btk Inhibitor PCI-32765 Support Comprehensive Program
Dec 9, 2010 07:39AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); ASH Meeting Data for Btk Inhibitor PCI-32765 Support the Company’s Plans
May 21, 2010 10:25AM 2010 ASCO Meeting Preview - Needham & Co Highlights ArQule (ARQL), Celldex (CLDX), Pharmacyclics (PCYC), and Seattle Genetics (SGEN)
May 13, 2010 08:11AM Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); FY3Q10 Review/Early FY4Q10 Preview
May 5, 2010 08:54AM Needham & Company Starts Pharmacyclics (PCYC) at Buy